Literature DB >> 33731053

Population migration, spread of COVID-19, and epidemic prevention and control: empirical evidence from China.

Zhen Hu1, Yuanyang Wu2, Mohan Su2, Lin Xie3, Anqi Zhang4, Xueyu Lin2, Yafeng Nie5.   

Abstract

BACKGROUND: This study applied the susceptible-exposed-infectious-removed (SEIR) model to analyze and simulate the transmission mechanisms of the coronavirus disease 2019 (COVID-19) in China.
METHODS: The population migration was embedded in the SEIR model to simulate and analyze the effects of the amount of population inflow on the number of confirmed cases. Based on numerical simulations, this study used statistical data for the empirical validation of its theoretical deductions and discussed how to improve the effectiveness of epidemic prevention and control considering population migration variables. Statistics regarding the numbers of infected people in various provinces were obtained from the epidemic-related data reported by China's National Health Commission.
RESULTS: This study explored how the epidemic should be prevented and controlled from the perspective of population migration variables. It found that the combination of a susceptible population, an infected population, and transmission media were important routes affecting the number of infections and that the migration of a Hubei-related infected population played a key role in promoting epidemic spread. Epidemic prevention and control should focus on regions with better economic conditions than the epidemic region. Prevention and control efforts should focus on the more populated neighboring provinces having convenient transportation links with the epidemic region. To prevent and control epidemic spread, priority should be given to elucidating the destinations and directions of population migration from the domestic origin of infections, and then controlling population migration or human-to-human contact after such migration.
CONCLUSIONS: This study enriched and expanded on simulations of the effects of population migration on the COVID-19 epidemic and China-based empirical studies while offering an epidemic evaluation and warning mechanism to prevent and control similar public health emergencies in the future.

Entities:  

Keywords:  COVID-19; Epidemic prevention and control; Population migration; Wuhan

Mesh:

Year:  2021        PMID: 33731053      PMCID: PMC7968569          DOI: 10.1186/s12889-021-10605-2

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  22 in total

1.  Thinking Globally, Acting Locally - The U.S. Response to Covid-19.

Authors:  Rebecca L Haffajee; Michelle M Mello
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 91.245

2.  Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis.

Authors:  Rui Huang; Miao Liu; Yongmei Ding
Journal:  J Infect Dev Ctries       Date:  2020-03-31       Impact factor: 0.968

3.  China's local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective.

Authors:  Fanghua Gong; Yong Xiong; Jian Xiao; Li Lin; Xiaodong Liu; Dezhong Wang; Xiaokun Li
Journal:  Front Med       Date:  2020-03-12       Impact factor: 4.592

4.  A mathematical model for the novel coronavirus epidemic in Wuhan, China.

Authors:  Cha Yu Yang; Jin Wang
Journal:  Math Biosci Eng       Date:  2020-03-11       Impact factor: 2.080

5.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.

Authors:  Kiesha Prem; Yang Liu; Timothy W Russell; Adam J Kucharski; Rosalind M Eggo; Nicholas Davies; Mark Jit; Petra Klepac
Journal:  Lancet Public Health       Date:  2020-03-25

6.  Data-based analysis, modelling and forecasting of the COVID-19 outbreak.

Authors:  Cleo Anastassopoulou; Lucia Russo; Athanasios Tsakris; Constantinos Siettos
Journal:  PLoS One       Date:  2020-03-31       Impact factor: 3.240

7.  Early dynamics of transmission and control of COVID-19: a mathematical modelling study.

Authors:  Adam J Kucharski; Timothy W Russell; Charlie Diamond; Yang Liu; John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Infect Dis       Date:  2020-03-11       Impact factor: 25.071

8.  The progress of 2019 novel coronavirus event in China.

Authors:  Guan Wang; Xian Jin
Journal:  J Med Virol       Date:  2020-02-26       Impact factor: 2.327

9.  The effect of human mobility and control measures on the COVID-19 epidemic in China.

Authors:  Moritz U G Kraemer; Chia-Hung Yang; Bernardo Gutierrez; Chieh-Hsi Wu; Brennan Klein; David M Pigott; Louis du Plessis; Nuno R Faria; Ruoran Li; William P Hanage; John S Brownstein; Maylis Layan; Alessandro Vespignani; Huaiyu Tian; Christopher Dye; Oliver G Pybus; Samuel V Scarpino
Journal:  Science       Date:  2020-03-25       Impact factor: 47.728

10.  Modeling the epidemic dynamics and control of COVID-19 outbreak in China.

Authors:  Shilei Zhao; Hua Chen
Journal:  Quant Biol       Date:  2020-03-11
View more
  4 in total

1.  COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted.

Authors:  Leyuan Liu; Xiaoxiao Wang; Xiaoguang Li; Nan Li
Journal:  Front Public Health       Date:  2022-05-06

2.  Panel Associations Between Newly Dead, Healed, Recovered, and Confirmed Cases During COVID-19 Pandemic.

Authors:  Ming Guan
Journal:  J Epidemiol Glob Health       Date:  2021-12-11

3.  Epidemiological Characteristics of Infectious Diseases Among Travelers Between China and Foreign Countries Before and During the Early Stage of the COVID-19 Pandemic.

Authors:  Zheng Luo; Wei Wang; Yibo Ding; Jiaxin Xie; Jinhua Lu; Wen Xue; Yichen Chen; Ruiping Wang; Xiaopan Li; Lile Wu
Journal:  Front Public Health       Date:  2021-11-03

4.  Influence of epidemic situation on COVID-19 vaccination between urban and rural residents in China-Vietnam border area: A cross-sectional survey.

Authors:  Bin Liu; Min Zhang; Xiangang Li; Li Liu; Qin Li; Zhengzhong Liang; Lin Xu; Li Li; Yuekang Su
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.